To assess the efficacy and safety of thrombolytic therapy in pulmonary thromboembolism.
Results of the review
Eight RCTs were included in the review with 237 participants in the intervention groups and 216 participants in the control groups. Follow-up ranged from 3 days to 12 months.
The average quality score using Jadad's criteria was 1.87 points, median 2 points, mode 1 point.
In the qualitative synthesis, 7 out of 8 RCTs found no differences in the resolution of the thrombus among both treatment groups 24 hours after the start of therapy. For mortality, no statistical differences were found between mortality rate of patients with PTE treated only with heparin and that of patients treated also with some type of thrombolytic drug. There are no differences either when comparing mortality rate of patients treated with thrombolytics with that of controls (heparin) if those treated with rt-PA and those treated with SK and UK are studied separately.
For relapses, the meta-analytic study of the clinical trials identified has not shown any statistically significant association between the type of therapy received and the presence of not of angiographically and/or gammagraphically confirmed thromboembolic relapses.
For risk of haemorrhage, PTE patients receiving thrombolytic therapy show a 2.5 fold higher risk of suffering some type of haemorrhage than PTE patients not receiving it (OR = 2.6, 95% CI: 1.6, 4.4). The results of the meta-analytic study regarding major bleeding show an OR = 1.87, 95% CI: 0.97, 3.61.
Authors' conclusions
There is little scientific evidence on the efficacy and effectiveness of thrombolytic therapy in PTE regarding the clinically relevant mid and long-term outcomes, such as mortality, relapses, remaining dyspnea, tolerance to exercise of quality of life, and regarding the efficacy and effectiveness of this therapy in the subpopulation of haemodynamically unstable patients with massive PTE.
CRD commentary
In this brief report, the authors have stated their research question but not the inclusion and exclusion criteria. The literature search appears thorough but the authors do not state their search terms so it is not possible to replicate the review without additional information. Since there is no mention of language restrictions or searching for unpublished material it is possible that additional relevant studies may have been missed. The quality of the included studies was formally assessed but the authors have not reported on how the articles were selected, and they do state how many of the reviewers were involved in the data scoring and extraction.
The data extraction is reported in tables and text. The statistical pooling was appropriate where performed. No tests for homogeneity were reported and there was no discussion of the methodological and data limitations in the review.
